OWC’s Tracy Williams talks to Variety about Hollywood’s zero tolerance policy

Times have changed, writes Variety’s Gene Maddaus. In the wake of the Weinstein scandal, dozens of men have been ousted for allegations of sexual misconduct. It was a long time coming, but when it came, it was sudden. Now the same urgency and zero-tolerance mentality are being applied to offensive statements as well as deeds.

“The studios haven’t behaved well. They have been bad actors,” said Tracy Williams, CEO of Olmstead Williams Communications. “Suddenly there’s a spotlight put on them, and they realize they need to button up. Every company is moving quickly. Heads are flying; look at all the people getting fired.”

Read the full article: Is Hollywood’s New Zero-Tolerance Policy a Reaction to the Trump Era? (Variety)

July 24th, 2018|Categories: OWC News|Tags: , , , , , |

Olmstead Williams Communications named to List of Largest Los Angeles PR Firms for ninth year

OWC has been named to the Los Angeles Business Journal’s 2018 list of the “75 Largest Public Relations Firms in Los Angeles County.”

OWC, celebrating its tenth year in business, has been on the list for each of the previous nine years, and continues to expand its service to the most innovative companies in healthcare, finance and technology.

“The current information war makes this an important time for public relations,” said Tracy Williams, CEO and founder. “We and our clients are on the front lines of explanatory journalism, where facts and rapid response are the keys to successful growth in every marketplace. It’s an honor for our success to be recognized.”

The LABJ list ranks public relations firms throughout Los Angeles according to number of employees and growth based on fee revenue.

See the full release here.

May 14th, 2018|Categories: OWC News|

CURE Pharmaceutical’s Steven Ruhl on raw materials and functional excipients

Steven Ruhl, VP of manufacturing for CURE Pharmaceutical, was featured in a roundtable in the April edition of the American Pharmaceutical Review on “Raw Materials and Functional Excipients.”

“Regulatory and quality expectations of excipients will continue to increase,” said Ruhl, “which has put more pressure on excipient and raw material companies to invest in characterizing functionality and building robust processes to consistently address company needs. This has led to a greater focus on understanding critical material attributes and ranges by both suppliers and customers earlier in the development process.”

Read the full article: Raw Materials and Functional Excipients (American Pharmaceutical Review)

OWC adds two healthcare leaders to client portfolio

OWC has been retained by two healthcare clients to its growing roster. CURE Pharmaceutical (OTC: CURR) is an innovative drug delivery company, and Saban Community Clinic is a federally-qualified health center providing low-cost, integrated health care to the Los Angeles community.

“Healthcare is one of the fastest growing markets in the country, and we are fortunate to work with two innovators,” said Tracy Williams, OWC founder and CEO. “CURE Pharmaceutical and Saban Community Clinic are two organizations that are changing patient’s lives and improving the delivery healthcare to those in need.”

Read the full announcement: Olmstead Williams Communications Adds Two Healthcare Leaders to Client Portfolio (iReach)